Torin Boyd

  • Recent Work
  • About
  • Contact
  • Archive
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Home
Show Navigation
All Galleries
Download

Suntory's blue rose laboratory { 76 images } Created 11 Jul 2019

Next
View: 25 | All

Loading ()...

  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_036.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_033.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_004.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_048.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_047.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_052.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_042.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_013.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_009.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_017.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_025.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_019.jpg
  • 05212018_Suntory_blue_roses_058.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_060.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_057.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_064.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_070.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_069.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_078.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_088.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_096.jpg
  • May 21, 2018, Seika, Japan: At his research lab, Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center displays his latest efforts at producing blue roses. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_098.jpg
  • May 21, 2018, Seika, Japan: This is Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center with his researchers Noriko Nakamura Ph. D.(long haired woman), and Naoka Okitsu (short haired woman). They in their lab with their latest efforts to produce blue roses and carnations. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_114.jpg
  • May 21, 2018, Seika, Japan: This is Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center with his researchers Noriko Nakamura Ph. D.(long haired woman), and Naoka Okitsu (short haired woman). They in their lab with their latest efforts to produce blue roses and carnations. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_115.jpg
  • May 21, 2018, Seika, Japan: This is Yoshikazu Tanaka, Ph.D., Senior General Manager of the Suntory World Research Center with his researchers Noriko Nakamura Ph. D.(long haired woman), and Naoka Okitsu (short haired woman). They in their lab with their latest efforts to produce blue roses and carnations. Tanaka, who for the past 28 years has been experimenting with this biotechnology at Suntory has come very close, but has not yet succeeded in producing a truly blue rose. Sought after by botanists and horticulturists since the nineteenth century, the blue rose is so elusive as roses lack genes that can produce blue pigment. To change this, Tanaka and his team isolated blue genes from petunias and introduced them into roses that produce a blue pigment called delphinidin. Achieving results in 2004, Suntory was granted government approval to begin marketing their genetically modified roses, and in 2009 began selling their first blue rose called "Applause". Tanaka however still feels challenged and is trying to produce a deep blue rose not only through genetics, but also with the aid of metal ions and compounds that enhance blue pigments called flavones. He is also experimenting with higher ph levels which also help to increase blue pigments. Tanaka and Suntory have also succeeded in producing blue carnations which adapt better to gene modification. In 1997 they began marking their blue "Moonseries" carnations and have since introduced other varieties using pansy genes. Currently these blue carnations are grown in Columbia and Ecuador and sold primarily in the USA and Europe. Due to Suntory holding early patents to this technology, they face no competition in the manufacturing of blue roses and carnations. The international floral market is a multi-billion dollar industry and if Suntory succeeds at producing a perfectly blue rose the market potential would be astounding. Photo by Torin Boyd.
    05212018_Suntory_blue_roses_119.jpg
Next